-
Mashup Score: 0Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider - 4 year(s) ago
Acromegaly patients, even those with IGF-1 values within the normal range receiving somatostatin receptor ligands (SRLs), often suffer from significant symptoms. It is not known to what extent patients’ medical providers are aware of the frequency and severity of acromegaly symptoms or level of treatment satisfaction with SRLs. This study sought to examine the concordance between outcomes…
Source: PituitaryCategories: Endocrinology, Latest HeadlinesTweet
Here is a link to the great paper referenced by @DrSusanSamson1. From @EBGeerMD and colleagues! #MidAtlanticAACE https://t.co/s0HF4YcjKA